Pfizer Inc. agreed to buy the obesity startup Metsera Inc. for an enterprise value of about $4.9 billion to bolster its pipeline after a key weight-loss pill foundered.
www.bloomberg.com
#Pfizer #Buy #Metsera #Billion #ObesityDrug #Boost
Pfizer to Buy Metsera for $4.9 Billion in Obesity-Drug Boost
